A clinical study on regional lymphatic chemotherapy using an activated carbon nanoparticle-epirubicin in patients with breast cancer.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Volumn 33, Issue 6, 2012, Pages 2341-2348

  Yang, Qian ^a   Wang, Xiao dong ^b   Chen, Jie ^b   Tian, Chun xiang ^b   Li, Hong jiang ^b   Chen, Yu Juan ^b   Lv, Qing ^b  

^a SICHUAN UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; CHARCOAL; EPIRUBICIN; NANOPARTICLE;

ADULT; AGED; APOPTOSIS; ARTICLE; BREAST TUMOR; CANCER STAGING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; INTRALYMPHATIC DRUG ADMINISTRATION; LYMPH NODE; LYMPH NODE METASTASIS; METASTASIS; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHARCOAL; EPIRUBICIN; FEMALE; HUMANS; INJECTIONS, INTRALYMPHATIC; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NANOPARTICLES; NEOPLASM STAGING; PROGNOSIS;

EID: 84873111534     PISSN: None     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-012-0496-y     Document Type: Article

References (0)